European Medicines Agency issues draft guidance on data integrity
The European Medicines Agency and the Pharmaceutical Inspection Co-operation Scheme have released draft guidance for pharmas on how to maintain data integrity during testing, manufacturing, packaging, distributing, and monitoring of medicines. Jaclyn Jaeger reports.
Related articles
-
ArticleSanctions, money-laundering and supply chains top agenda for energy sector compliance
The energy sector faces rising regulatory activity, with more rules and enforcement. Bribery, corruption, and sanctions now dominate compliance concerns, driving rapid change and pressure on compliance officers.
-
ArticleComplying with the EU Data Act – What companies should know
Companies could face significant compliance challenges in trying to meet new EU legal requirements about how companies share data with third parties.
-
PremiumNew EU Data Act may impact companies’ GDPR compliance efforts
New rules that have recently come into effect across the EU will allow for greater transfers of data between companies, though experts fear the changes could conflict with Europe’s strict privacy legislation, which protects personal information.